Cetera Investment Advisers’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.14M | Buy |
|
|||||
|
2025
Q2 | $2.34M | Sell |
|
|||||
|
2025
Q1 | $1.97M | Buy |
|
|||||
|
2024
Q4 | $1.17M | Sell |
|
|||||
|
2024
Q3 | $1.67M | Buy |
|
|||||
|
2024
Q2 | $1.45M | Sell |
|
|||||
|
2024
Q1 | $2.32M | Buy |
|
|||||
|
2023
Q4 | $387K | Buy |
|
|||||
|
2023
Q3 | $261K | Buy |
|
|||||
|
2023
Q2 | $320K | Sell |
|
|||||
|
2023
Q1 | $372K | Sell |
|
|||||
|
2022
Q4 | $350K | Buy |
|
|||||
|
2022
Q3 | $434K | Sell |
|
|||||
|
2022
Q2 | $490K | Buy |
|
|||||
|
2022
Q1 | $491K | Buy |
|
|||||
|
2021
Q4 | $528K | Sell |
|
|||||
|
2021
Q3 | $808K | Buy |
|
|||||
|
2021
Q2 | $1.04M | Buy |
|
|||||
|
2021
Q1 | $563K | Sell |
|
|||||
|
2020
Q4 | $783K | Buy |
|